Health Services Research
Latest posts by Health Services Research (see all)
- Income Dynamics and the Affordable Care Act - Oct. 20, 2014
- Payment Rates for Personal Care Assistants and the Use of Long-Term Services and Supports among… - Oct. 18, 2014
- Development of a Novel, Objective Measure of Health Care–Related Financial Burden for U.S…. - Oct. 18, 2014
- Population-Level Cost-Effectiveness of Implementing Evidence-Based Practices into Routine Care - Oct. 18, 2014
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.